PMID- 10995005 OWN - NLM STAT- MEDLINE DCOM- 20001006 LR - 20190915 IS - 0887-6924 (Print) IS - 0887-6924 (Linking) VI - 14 IP - 9 DP - 2000 Sep TI - GTP-mediated differentiation of the human K562 cell line: transient overexpression of GATA-1 and stabilization of the gamma-globin mRNA. PG - 1589-97 AB - Induction of specific gene expression may provide an alternative or a support to conventional cytotoxic chemotherapy of cancer, as well as to therapy for sickle cell diseases. In this respect, pharmacological induction of expression of the endogenous gamma-globin gene is a realistic approach to therapy of beta-globin disorders. Erythroid differentiation and inhibition of proliferation of the human CML K562 cell line was induced by guanosine 5'-triphosphate (GTP). The hemoglobin production in cells was correlated to an increase in alpha- and gamma-globin mRNA expression. At the transcriptional level, we showed that both the expression of the major erythroid transcription factor GATA-1 (protein and mRNA) and its binding capacity to the gamma-globin gene promoter was transiently increased. Moreover, GTP moderately stimulated the gamma-globin gene promoter after 48 h of treatment. At the post-transcriptional level, GTP treatment led to a drastic increase of the gamma-globin mRNA half-life. This stabilizing effect of GTP was mediated via the 3'-untranslated region (3'-UTR) of the gamma-globin mRNA. In conclusion, mechanism of GTP-mediated differentiation of K562 cells is linked to an early activation of gamma-globin gene transcription followed by a stabilization of its mRNA. FAU - Morceau, F AU - Morceau F AD - Laboratoire de Recherche sur le Cancer et les Maladies du Sang, Centre Universitaire de Luxembourg, France. FAU - Dupont, C AU - Dupont C FAU - Palissot, V AU - Palissot V FAU - Borde-Chiche, P AU - Borde-Chiche P FAU - Trentesaux, C AU - Trentesaux C FAU - Dicato, M AU - Dicato M FAU - Diederich, M AU - Diederich M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Leukemia JT - Leukemia JID - 8704895 RN - 0 (DNA-Binding Proteins) RN - 0 (Erythroid-Specific DNA-Binding Factors) RN - 0 (GATA1 Transcription Factor) RN - 0 (GATA1 protein, human) RN - 0 (RNA, Messenger) RN - 0 (Transcription Factors) RN - 86-01-1 (Guanosine Triphosphate) RN - 9004-22-2 (Globins) SB - IM MH - DNA-Binding Proteins/*biosynthesis/genetics MH - Erythroid-Specific DNA-Binding Factors MH - Erythropoiesis/genetics/*physiology MH - GATA1 Transcription Factor MH - Gene Expression Regulation, Neoplastic MH - Globins/genetics/*metabolism MH - Guanosine Triphosphate/*physiology MH - Humans MH - K562 Cells MH - Promoter Regions, Genetic/genetics MH - RNA Stability MH - RNA, Messenger/metabolism MH - Transcription Factors/*biosynthesis/genetics EDAT- 2000/09/20 11:00 MHDA- 2000/10/14 11:01 CRDT- 2000/09/20 11:00 PHST- 2000/09/20 11:00 [pubmed] PHST- 2000/10/14 11:01 [medline] PHST- 2000/09/20 11:00 [entrez] AID - 10.1038/sj.leu.2401890 [doi] PST - ppublish SO - Leukemia. 2000 Sep;14(9):1589-97. doi: 10.1038/sj.leu.2401890.